GeminIQ Website Logo

Viewing NERV free

Subscribe for full history, 90+ metrics, screener, watchlist...

Minerva Neurosciences, Inc.

NERV

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
253382121517212731354147
Marketable Securities Current
5145----------
Restricted Cash Current
000000000000
Prepaid Expense Current
411101110111
Assets Current
807983131618222831364248
Capitalized Computer Software Net
------000000
Property Plant And Equipment Net
--0000000000
Goodwill
151515151515151515151515
Assets
959498283033374346515763
Liabilities And Stockhold…
Liabilities
Liabilities Current
Accounts Payable Current
121111211121
Accounts Payable And Other Accrued Liabilities Cur…
322221143122
Liabilities Current
442332344333
Liabilities
297343234636362636491878583
Temporary Equity
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
583560548371370370370369369369368368
Retained Earnings Accumulated Deficit
-797-814-689-405-402-399-395-391-414-405-397-388
Stockholders Equity
-213-254-141-35-32-29-26-22-44-37-28-20
Liabilities And Stockholders Equity
959498283033374346515763
Series A Convertible Preferred Stock
-00---------
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
100100100100100100100100100100100100
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
250250250125125125125125125125125125
Common Stock Shares Issued
474443777777777
Shares Outstanding
474443777777777

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-21.44%-30.08%-35.36%---------
202512.88%1.23%17.36%30.92%16.99%133.98%9.42%9.69%3.93%-27.67%-16.85%-32.74%
20241.75%43.33%30.83%-6.80%-8.16%-17.01%-4.45%-4.24%-8.47%0.56%-10.61%-16.20%
2023------37.83%16.92%54.75%-61.52%-65.52%-67.03%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
20.14
17.65
36.28
4.87
6.15
9.21
7.85
6.23
7.47
12.58
12.57
14.40
Quick Ratio
19.04
17.44
35.98
4.64
6.07
8.93
7.57
5.94
7.37
12.34
12.28
14.03
Working Capital
75.77M
74.62M
80.81M
10.35M
13.02M
15.98M
19.43M
23.45M
27.21M
32.79M
38.66M
44.88M
Leverage & Debt
Debt to Equity
-1.39
-1.35
-1.66
-1.81
-1.95
-2.13
-2.45
-2.98
-2.04
-2.38
-3.00
-4.15
Debt Ratio
3.12
3.65
2.39
2.23
2.06
1.89
1.69
1.51
1.96
1.72
1.50
1.32
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-4.99
-9.45
-34.67
-1.85
1.48
0.83
0.19
-0.44
-4.45
-4.18
-4.61
-3.66
Free Cash Flow Per Share TTM
-0.56
-0.34
-1.60
-1.88
-2.07
-2.32
-2.58
-2.69
-2.75
-2.74
-2.27
-1.71
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
-3,611.70%
-6,736.21%
-20,492.68%
323.60%
-133.38%
-119.79%
-104.80%
-88.05%
25.59%
7.81%
-6.55%
-40.65%
EPS Growth (1Y)
-670.40%
-1,244.16%
-18,337.18%
323.60%
-133.38%
-119.79%
-104.12%
-88.05%
-8.55%
-23.94%
-23.30%
-58.13%
Valuation Metrics
P/E TTM
-0.66
-0.64
-0.12
-1.14
1.16
2.06
11.69
-6.10
-0.72
-0.62
-1.33
-1.88
P/B TTM
-1.21
-1.04
-0.24
-0.46
-0.41
-0.44
-0.65
-0.93
-0.54
-0.53
-1.41
-2.61
Market Cap
258.62M
264.50M
34.02M
15.93M
13.02M
12.87M
16.82M
20.21M
24.15M
19.53M
40.01M
52.23M
Enterprise Value
233.87M
231.74M
-3.25M
3.65M
-2.33M
-4.52M
-4.54M
-6.32M
-6.74M
-15.39M
-998.39K
5.32M
Calculated Values
Free Cash Flow TTM
-26.17M
-14.87M
-13.51M
-14.20M
-15.63M
-17.53M
-19.55M
-20.38M
-20.83M
-20.76M
-14.78M
-12.92M
Net Debt
-24.75M
-32.76M
-37.28M
-12.29M
-15.35M
-17.39M
-21.36M
-26.53M
-30.88M
-34.92M
-41.01M
-46.90M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2023-05-02Sale
Owner: Luthringer, Remy
Title: CEO
Shares: 3,641
Price/Share: $3.76
Value: $13,690.16
Shares Owned: 68,994
Relationship: Director,Officer
Ownership: Direct
2023-05-01Sale
Owner: Race, Geoff
Title: President
Shares: 22,082
Price/Share: $3.85
Value: $85,015.70
Shares Owned: 51,324
Relationship: Officer
Ownership: Direct
2023-05-01Sale
Owner: Ahlholm, Frederick W
Title: SVP, CFO and Secretary
Shares: 3,580
Price/Share: $4.48
Value: $16,038.40
Shares Owned: 17,518
Relationship: Officer
Ownership: Direct
2021-12-01Sale
Owner: Kupfer, David
Title: -
Shares: 55,635
Price/Share: $0.88
Value: $48,958.80
Shares Owned: 163,553
Relationship: Director
Ownership: Direct
2020-12-16Sale
Owner: Luthringer, Remy
Title: CEO
Shares: 1,300
Price/Share: $2.64
Value: $3,432.00
Shares Owned: 66,490
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
87.23%
Inst. Shares: 38,293,011
Shares Outstanding: 43,900,426
2025-12-31
272.48%
Inst. Shares: 23,061,322
Shares Outstanding: 8,463,581
2025-09-30
25.92%
Inst. Shares: 1,961,856
Shares Outstanding: 7,568,981
2025-06-30
25.46%
Inst. Shares: 1,927,067
Shares Outstanding: 7,568,981
2025-03-31
25.56%
Inst. Shares: 1,934,418
Shares Outstanding: 7,568,981

Minerva Neurosciences, Inc. (NERV) — SEC Financial Statements & Analysis

Minerva Neurosciences, Inc. (NERV) is a pharmaceutical preparations company, incorporated in MA. Minerva Neurosciences, Inc. trades on Nasdaq as: NERV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Minerva Neurosciences, Inc. reported a Debt-to-Equity ratio of -1.39x, a Price-to-Book (P/B) ratio of -1.21x (TTM), at a market cap of $258.62M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
-1.39x
P/B TTM
-1.21x
Market Cap
$258.62M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Minerva Neurosciences, Inc. in?

Minerva Neurosciences, Inc. (NERV) operates in the Pharmaceutical Preparations industry.

What is NERV's market cap?

Minerva Neurosciences, Inc. (NERV) has a market capitalization of $258.62M as of 2026-06-30.

What exchange does NERV trade on?

Minerva Neurosciences, Inc. (NERV) trades on the Nasdaq.

Where is Minerva Neurosciences, Inc. incorporated?

Minerva Neurosciences, Inc. is incorporated in MA.

Wall Street's data.
Main Street's price.